Neurim

Neurim Pharmaceuticals is a neuroscience drug discovery and development company dedicated to developing drugs for brain repair and enhancement, focusing on the central nervous system. Circadin® is the company's new product for treating insomnia, which was approved by the European Commission on June 29, 2007, and is currently sold in Europe, the Asia-Pacific region, Latin America, Africa, and the Middle East. Other products are NCEs in preclinical and clinical development. The company focuses on aging-related diseases such as insomnia and neurodegenerative diseases with the goal of improving quality of life.